Premium
Delineation of Receptor‐Ligand Interactions at the Human Histamine H 1 Receptor by a Combined Approach of Site‐Directed Mutagenesis and Computational Techniques – or – How to Bind the H 1 Receptor
Author(s) -
Jongejan Aldo,
Leurs Rob
Publication year - 2005
Publication title -
archiv der pharmazie
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.468
H-Index - 61
eISSN - 1521-4184
pISSN - 0365-6233
DOI - 10.1002/ardp.200400998
Subject(s) - g protein coupled receptor , chemistry , histamine receptor , histamine , histamine h4 receptor , stereochemistry , agonist , receptor , inverse agonist , histamine h3 receptor , ligand (biochemistry) , histamine h2 receptor , rhodopsin , histamine h1 receptor , mutagenesis , binding site , partial agonist , pharmacology , biochemistry , antagonist , biology , mutation , retinal , gene
Histamine H 1 antagonists or “antihistamines” are one of the most prescribed drug families in Western countries. They exert their effect by binding to the histamine H 1 receptor, a receptor belonging to the class of rhodopsin‐like G protein‐coupled receptors (GPCRs). In this review, the binding of ligands to the human histamine H 1 receptor with respect to site‐directed mutagenesis studies and molecular modeling techniques is described. The ligands described include agonists (histamine and histapro difens), a stereoselective partial agonist (lisuride), and selected inverse agonists (mepyramine, acrivastine and triprolidine).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom